PAA 8.89% 20.5¢ pharmaust limited

Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3, page-33

  1. 145 Posts.
    lightbulb Created with Sketch. 40
    Agree. If 10% market share is already giving us A$0.89 per share, imagine 30% or 50%... They also applied a 30% probability on future cashflows post commercialization so I assume the NPV will be more than tripled if the drug does get approved for ALS/MND.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.020(8.89%)
Mkt cap ! $81.16M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $331.9K 1.617M

Buyers (Bids)

No. Vol. Price($)
4 440882 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 12736 3
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.